Concepedia

Jay Overholser

JO

Statistics

Publications

12

Citations

841

H-Index

11

Active since

2000

Affiliations

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute(Current)

The Ohio State University

Emory University

The Ohio State University Wexner Medical Center

Columbus Oncology and Hematology Associates

Jay Overholser is an author at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute specializing in oncology, medicine, and immunotherapy.

Publications per year

2000–2022

12

Publications

12

Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.

Rolf A. Brekken, Jay Overholser, Victor Stastny et al. · PubMed · 2000 · 311 citations

, , +16

Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice

Jay Overholser, Marie Prewett, Andrea T. Hooper et al. · Cancer · 2000 · 162 citations · Full text

, , +15

Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.

Fang Liao, Jacqueline Doody, Jay Overholser et al. · PubMed · 2002 · 106 citations

, , +17

Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors

Tanios Bekaii‐Saab, Robert Wesolowski, Daniel H. Ahn et al. · Clinical Cancer Research · 2019 · 65 citations · Full text

, , +17

Peptide Vaccines and Peptidomimetics of EGFR (HER-1) Ligand Binding Domain Inhibit Cancer Cell Growth In Vitro and In Vivo

Kevin Foy, Ruthie M. Wygle, Megan Miller et al. · The Journal of Immunology · 2013 · 43 citations

, , +17

1–5 of 12